There are also various facets of cancer progression that could be influenced by upregulation of p70S6K activity or its constitutive activation, such as cancer stemness, the epithelial-mesenchymal transition [9–11], and drug resistance [12]. The gene discussed is RPS6KB1; the disease is cancer.